18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients
![]() |
Youn, Seok Hwa
(Department of Surgery, Kosin University College of Medicine)
Seo, Kyung Won (Department of Surgery, Kosin University College of Medicine) Lee, Sang Ho (Department of Surgery, Kosin University College of Medicine) Shin, Yeon Myung (Department of Surgery, Kosin University College of Medicine) Yoon, Ki Young (Department of Surgery, Kosin University College of Medicine) |
1 | Marczell AP, Rosen HR, Hentschel E. Diagnosis and tactical approach to surgery for early gastric carcinoma: a retrospective analysis of the past 16 years in an Austrian general hospital. Gastroenterol Jpn 1989;24:732-736. |
2 | Han EJ, Choi WH, Chung YA, Kim KJ, Maeng LS, Sohn KM, et al. Comparison between FDG uptake and clinicopathologic and immunohistochemical parameters in pre-operative PET/CT scan of primary gastric carcinoma. Nucl Med Mol Imaging 2009;43:26-34. |
3 | Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF. Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 2006;243:189-195. DOI ScienceOn |
4 | Yeung HW, Macapinlac H, Karpeh M, Finn RD, Larson SM. Accuracy of FDG-PET in gastric cancer. Preliminary experience. Clin Positron Imaging 1998;1:213-221. DOI ScienceOn |
5 | Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 2001;92:634-641. DOI ScienceOn |
6 | Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9. DOI ScienceOn |
7 | Kim JP. Surgical results in gastric cancer. Semin Surg Oncol 1999;17:132-138. DOI ScienceOn |
8 | Kim EY, Lee WJ, Choi D, Lee SJ, Choi JY, Kim BT, et al. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol 2011;79:183-188. DOI ScienceOn |
9 | Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 2004;28:247-253. DOI ScienceOn |
10 | Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDGPET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol 2009;35:449-455. DOI ScienceOn |
11 | Kim SK, Kang KW, Lee JS, Kim HK, Chang HJ, Choi JY, et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006;33:148-155. DOI ScienceOn |
12 | Hiki Y, Shimao J, Yamao Y, Kobayashi N, Kuranami M, Kikuchi S, et al. The concepts, procedures, and problems related in endoscopic laser therapy of early gastric cancer. A retrospective study on early gastric cancer. Surg Endosc 1989;3:1-6. DOI ScienceOn |
13 | Ohgami M, Otani Y, Kumai K, Kubota T, Kim YI, Kitajima M. Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg 1999;23:187-192. DOI ScienceOn |
14 | Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003;30:288-295. DOI ScienceOn |
15 | Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, et al. Preoperative staging of non-smallcell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254-261. DOI ScienceOn |
16 | Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, et al. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med 2005;46:1582-1588. |
17 | Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging 2009;34:441-447. DOI ScienceOn |
18 | Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007;8:797-805. DOI ScienceOn |
19 | Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-3210. DOI |
20 | Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. Staging non-small cell lung cancer by wholebody positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-1581. DOI ScienceOn |
21 | Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-26. DOI ScienceOn |
22 | Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521-527. DOI ScienceOn |
23 | Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer 2006;9:192-196. DOI ScienceOn |
24 | Ott K, Fink U, Becker K, Stahl A, Dittler HJ, Busch R, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 2003;21:4604-4610. DOI ScienceOn |
![]() |